Table 2: Acute Flare and Long-term Management Therapies in Dogs
Download a PDF of Table 2
| Drug Name | Acute Flare | Long-term Management | Advantage/Disadvantage |
|---|---|---|---|
| Oclacitinib |
✓ |
✓ |
|
|
|||
| Lokivetmab |
✓ |
✓ |
|
|
|||
| Corticosteroids |
✓ |
✓ |
|
|
|||
| Allergen-specific immunotherapy |
X |
✓ |
|
|
|||
| Cyclosporine |
X |
✓ |
|
|
|||
| EFAs |
X |
✓ |
|
|
|||
| Antihistamines |
X |
✓ |
|
|
EFAs, essential fatty acids.
The 2023 AAHA Management of Allergic Skin Diseases in Dogs and Cats Guidelines are generously supported by Hill’s Pet Nutrition, Merck Animal Health, and Zoetis.